166 related articles for article (PubMed ID: 30803559)
21. In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia.
Strullu M; Caye A; Cassinat B; Fenneteau O; Touzot F; Blauwblomme T; Rodriguez R; Latour S; Petit A; Barlogis V; Galambrun C; Leblanc T; Baruchel A; Chomienne C; Cavé H
Leukemia; 2013 Dec; 27(12):2404-7. PubMed ID: 23823657
[No Abstract] [Full Text] [Related]
22. Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant.
Stellacci E; Carter JN; Pannone L; Stevenson D; Moslehi D; Venanzi S; ; Bernstein JA; Tartaglia M; Martinelli S
Am J Med Genet A; 2024 Apr; ():e63627. PubMed ID: 38613168
[TBL] [Abstract][Full Text] [Related]
23. A Case of Pheochromocytoma as a Subsequent Neoplasm in a Survivor of Childhood Embryonal Rhabdomyosarcoma.
Rodwin RL; Janardan SK; Hofstatter EW; Kadan-Lottick NS
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e585-e588. PubMed ID: 35200227
[TBL] [Abstract][Full Text] [Related]
24. Tracing the development of acute myeloid leukemia in CBL syndrome.
Becker H; Yoshida K; Blagitko-Dorfs N; Claus R; Pantic M; Abdelkarim M; Niemöller C; Greil C; Hackanson B; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Döhner K; Schnittger S; Henneke P; Niemeyer CM; Flotho C; Pfeifer D; Ogawa S; Lübbert M
Blood; 2014 Mar; 123(12):1883-6. PubMed ID: 24493670
[TBL] [Abstract][Full Text] [Related]
25. Adult-onset acute myeloid leukaemia in a patient with germline mutation of CBL.
Ali AM; Cooper J; Walker A; Jones D; Saad A
Br J Haematol; 2021 Feb; 192(3):665-667. PubMed ID: 33216958
[No Abstract] [Full Text] [Related]
26. Transient immune deficiency accompanied with homozygous CBL rare variant.
Morishita A; Yeh TW; Tomari K; Furuichi M; Kashimada K; Morio T; Takagi M; Imai K
Pediatr Int; 2023 Jan; 65(1):e15439. PubMed ID: 36495474
[TBL] [Abstract][Full Text] [Related]
27. DICER1-Related Embryonal Rhabdomyosarcoma of the Uterine Corpus in a Prepubertal Girl.
Dural O; Kebudi R; Yavuz E; Yilmaz I; Buyukkapu Bay S; Schultz KAP; Hill DA
J Pediatr Adolesc Gynecol; 2020 Apr; 33(2):173-176. PubMed ID: 31838154
[TBL] [Abstract][Full Text] [Related]
28. Concurrent somatic KRAS mutation and germline 10q22.3-q23.2 deletion in a patient with juvenile myelomonocytic leukemia, developmental delay, and multiple malformations: a case report.
Yao R; Yu T; Xu Y; Li G; Yin L; Zhou Y; Wang J; Yan Z
BMC Med Genomics; 2018 Jul; 11(1):60. PubMed ID: 30012129
[TBL] [Abstract][Full Text] [Related]
29. Primary Graft Failure but Treatment Success: A Case of Reversion to Heterozygosity After Allogeneic Hematopoietic Cell Transplantation With Autologous Hematopoietic Recovery in a Child With CBL-related Juvenile Myelomonocytic Leukemia.
Oshrine B
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e426-e428. PubMed ID: 32032248
[TBL] [Abstract][Full Text] [Related]
30. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.
Koelsche C; Mynarek M; Schrimpf D; Bertero L; Serrano J; Sahm F; Reuss DE; Hou Y; Baumhoer D; Vokuhl C; Flucke U; Petersen I; Brück W; Rutkowski S; Zambrano SC; Garcia Leon JL; Diaz Coronado RY; Gessler M; Tirado OM; Mora J; Alonso J; Garcia Del Muro X; Esteller M; Sturm D; Ecker J; Milde T; Pfister SM; Korshunov A; Snuderl M; Mechtersheimer G; Schüller U; Jones DTW; von Deimling A
Acta Neuropathol; 2018 Aug; 136(2):327-337. PubMed ID: 29881993
[TBL] [Abstract][Full Text] [Related]
31. Congenital embryonal rhabdomyosarcoma caused by heterozygous concomitant PTCH1 and PTCH2 germline mutations.
Taeubner J; Brozou T; Qin N; Bartl J; Ginzel S; Schaper J; Felsberg J; Fulda S; Vokuhl C; Borkhardt A; Kuhlen M
Eur J Hum Genet; 2018 Jan; 26(1):137-142. PubMed ID: 29230040
[TBL] [Abstract][Full Text] [Related]
32. Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.
Hecht A; Meyer JA; Behnert A; Wong E; Chehab F; Olshen A; Hechmer A; Aftandilian C; Bhat R; Choi SW; Chonat S; Farrar JE; Fluchel M; Frangoul H; Han JH; Kolb EA; Kuo DJ; MacMillan ML; Maese L; Maloney KW; Narendran A; Oshrine B; Schultz KR; Sulis ML; Van Mater D; Tasian SK; Hofmann WK; Loh ML; Stieglitz E
Haematologica; 2022 Jan; 107(1):178-186. PubMed ID: 33375775
[TBL] [Abstract][Full Text] [Related]
33. Embryonal rhabdomyosarcoma in a patient with a heterozygous frameshift variant in the DICER1 gene and additional manifestations of the DICER1 syndrome.
Fremerey J; Balzer S; Brozou T; Schaper J; Borkhardt A; Kuhlen M
Fam Cancer; 2017 Jul; 16(3):401-405. PubMed ID: 27896549
[TBL] [Abstract][Full Text] [Related]
34. Embryonal rhabdomyosarcoma arising in the ureter.
Droc CL; Khanna P; Paidas CN; Gilbert-Barness E
Fetal Pediatr Pathol; 2008; 27(1):1-11. PubMed ID: 18568985
[TBL] [Abstract][Full Text] [Related]
35. A novel t(2;20)(q35;p12) in embryonal rhabdomyosarcoma.
Ho RH; Johnson J; Dev VG; Whitlock JA
Cancer Genet Cytogenet; 2004 May; 151(1):73-7. PubMed ID: 15120913
[TBL] [Abstract][Full Text] [Related]
36. Report of a bi-allelic truncating germline mutation in TP53.
Brown NJ; Bhatia K; Teague J; White SM; Lo P; Challis J; Beshay V; Sullivan M; Malkin D; Hansford JR
Fam Cancer; 2019 Jan; 18(1):101-104. PubMed ID: 29737433
[TBL] [Abstract][Full Text] [Related]
37. Rhabdomyosarcoma-associated renal cell carcinoma: a link with constitutional Tp53 mutation.
Curry S; Ibrahim F; Grehan D; McDermott M; Capra M; Betts D; O'Sullivan M
Pediatr Dev Pathol; 2011; 14(3):248-51. PubMed ID: 21054160
[TBL] [Abstract][Full Text] [Related]
38. Morphologic and Immunophenotypic Differences in Juvenile Myelomonocytic Leukemias With CBL and Other Canonical RAS-pathway Gene Mutations: A Single Institutional Experience.
Mariani RA; Jennings L; Zhang S; Bhat R; Gong S
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e819-e825. PubMed ID: 33769390
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies.
Hamadou WS; Bourdon V; Gaildrat P; Besbes S; Fabre A; Youssef YB; Regaieg H; Laatiri MA; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Jemni SY; Noguchi T; Khélif A; Sobol H; Soua Z
Ann Hematol; 2016 Jun; 95(7):1043-50. PubMed ID: 27106701
[TBL] [Abstract][Full Text] [Related]
40. CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.
Watanabe J; Sato K; Osawa Y; Horiuchi T; Kato S; Hikota-Saga R; Maekawa T; Yamamura T; Kobayashi A; Kobayashi S; Kimura F
Int J Hematol; 2018 Jul; 108(1):47-57. PubMed ID: 29600428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
